StonvexLoading…
StonvexStonvexStonvexCore line items from CSL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.02B | $5.00B | $4.59B | $5.45B |
Operating Income | $1.00B | $1.14B | $982.80M | $1.20B |
Net Income | $740.70M | $1.31B | $767.40M | $924.00M |
EPS (Diluted) | $17.12 | $27.82 | $15.18 | $17.56 |
Total Assets | $6.26B | $5.82B | $6.62B | $7.22B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.11B | $753.50M | $576.70M | $364.80M |
Free Cash Flow OCF − CapEx | $970.60M | $917.00M | $1.06B | $817.40M |
Shares Outstanding | 41.00M | 44.40M | 47.70M | 50.90M |